• Structure-Guided Development of MNK1/2 Inhibitors for Transl

  2026-07-07

  This study details the rational design of a highly selective dual MNK1/2 inhibitor (eFT508, Tomivosertib) to target dysregulated mRNA translation, a key driver of tumorigenesis. By leveraging crystal structure insights, the research establishes a framework for modulating the MNK-eIF4E axis with strong therapeutic selectivity, illuminating new opportunities in translational and cancer biology.

• Lovastatin as a Research Tool: Molecular Dynamics and Beyond

  2026-07-07

  Explore how Lovastatin, a potent HMG-CoA reductase inhibitor, shapes advanced research through its precise molecular effects on cholesterol biosynthesis, cell proliferation, and apoptosis. This article provides an in-depth, protocol-driven perspective with unique insights derived from recent findings.

• SAR405: Redefining Vps34 Inhibition for Advanced Autophagy R

  2026-07-06

  Explore how SAR405, a highly selective Vps34 inhibitor from APExBIO, is transforming autophagy and vesicle trafficking research. This thought-leadership article integrates the latest mechanistic insights—especially paradigm-shifting AMPK-ULK1 findings—with experimental best practices and strategic recommendations for translational researchers. Distinct from standard product overviews, we examine SAR405’s impact across cancer and neurodegenerative models, highlight rigorous protocol considerations, and provide a forward-looking perspective on the future of autophagy-targeted discovery.

• HyperPFU™ High-Fidelity DNA Polymerase: Practical PCR Guidan

  2026-07-06

  HyperPFU™ high-fidelity DNA polymerase provides robust, accurate PCR amplification for long or GC-rich DNA templates, where standard enzymes often fail. It is best suited for workflows that require blunt-ended, high-fidelity PCR products and is not appropriate for protocols needing 3'-A overhangs or sticky ends.

• Modeling Human Pacemaker Maturation with SAN-Plexus Assemblo

  2026-07-05

  The reference study introduces a human stem cell-derived tri-assembloid system that integrates sinoatrial node and cardiac plexus organoids to model pacemaker maturation under neural influence. This approach enables mechanistic dissection of neuron-to-pacemaker signaling, providing new insight into human cardiac development and conduction disorders.

• URB597 (KDS-4103): Reliable FAAH Inhibition for Endocannabin

  2026-07-04

  This authoritative guide explores how URB597 (SKU A4372) from APExBIO addresses real-world challenges in FAAH inhibition, offering robust, reproducible outcomes for neuroplasticity and neuroinflammation research. Scenario-driven Q&A blocks illustrate practical workflows, vendor reliability, and data interpretation strategies—grounded in validated protocols and literature. Researchers can leverage URB597 to enhance assay consistency and endocannabinoid signaling studies.

• Nutlin-3a: Advanced Insight Into MDM2 Inhibition and p53 Pat

  2026-07-03

  Explore the molecular precision of Nutlin-3a as a potent MDM2 inhibitor, uniquely dissecting its mechanistic impact on p53 stabilization and apoptosis in cancer research. This article delivers an in-depth, evidence-based analysis, bridging new methodological insights for experimental design.

• Topological Stress and Persistent rDNA Lesions: PML-Nucleola

  2026-07-03

  This study reveals how topological stress and RNA polymerase I inhibition create persistent DNA damage within ribosomal DNA, leading to the formation of PML-nucleolar compartments (PNAs). Findings clarify the chromatin and DNA repair dynamics at rDNA, with implications for genome stability, senescence, and cancer research.

• GLP-1 (9-36) amide: Precision Antagonist for GLP-1R Studies

  2026-07-02

  GLP-1 (9-36) amide empowers researchers to dissect GLP-1 receptor signaling with unmatched selectivity, overcoming traditional barriers in metabolic and diabetes research. Its unique antagonist profile and handling requirements enable robust, reproducible workflows for probing GPCR pathways and metabolic regulation.

• GANT61 Induces Apoptosis in ALK+ ALCL via Hh–PIK3IP1–Akt Axi

  2026-07-02

  This study demonstrates that GANT61, a Gli1/2 inhibitor, suppresses proliferation and induces apoptosis in ALK-positive anaplastic large cell lymphoma (ALCL) by modulating the Hedgehog–PIK3IP1–Akt signaling axis. The mechanistic insights clarify how direct targeting of Gli1 impacts tumor growth and survival, informing future strategies for targeted lymphoma therapies.

• Viperin Disrupts Coronavirus RTC via nsp8 Interaction and dd

  2026-07-01

  This study reveals that viperin restricts coronavirus replication by directly targeting non-structural protein 8 (nsp8), disrupting the assembly of the replication-transcription complex (RTC). The work highlights both ddhCTP-dependent and independent antiviral mechanisms and identifies conserved protein interaction domains, providing new targets for broad-spectrum antiviral strategies.

• Acetoacetic Acid Sodium Salt in Energy Metabolism Research

  2026-07-01

  Acetoacetic acid sodium salt is a benchmark metabolite for probing fatty acid catabolism and diabetic metabolic imbalance, offering unmatched purity and reproducibility. This guide details optimized workflows, key innovations, and troubleshooting strategies to advance translational energy metabolism and diabetes research.

• Dabigatran Etexilate: Oral Thrombin Inhibition in VTE and AF

  2026-06-30

  The reference study establishes dabigatran etexilate as the first oral, reversible direct thrombin inhibitor, offering predictable anticoagulation without routine monitoring. This innovation addresses major limitations of traditional therapies in venous thromboembolism (VTE) prevention and atrial fibrillation-related stroke, with significant implications for both clinical research and future protocol optimization.

• Dabigatran Etexilate: Reducing Drug Interactions in Anticoag

  2026-06-30

  The reference study details the clinical and pharmacokinetic advantages of dabigatran etexilate, the first oral direct thrombin inhibitor approved for stroke and VTE prevention. By being metabolized independent of the CYP450 system, dabigatran etexilate minimizes drug-drug interactions and monitoring requirements, marking a significant advance over traditional anticoagulants.

• JNJ-10198409: Precision Platelet-Derived Growth Factor Recep

  2026-06-29

  JNJ-10198409 provides nanomolar-precision PDGF-BB receptor inhibition for reproducible antiangiogenic and antiproliferative research. This guide details experimental workflows, key protocol parameters, and troubleshooting strategies that maximize data reliability in cancer biology and fibrotic disorder studies.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page